TrialCancer research communications2025
Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors.
Funda Meric-Bernstam et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled itcites it